Article
Serum miRNA biomarker discovery for placenta accreta spectrum
29 Sept 2020
Abstract excerpt
Placenta accreta spectrum (PAS) disorder is a major cause of maternal and fetal morbidity, and in vitro biomarkers are highly desired in clinic. This study enrolled three phases of 186 pregnant women, including controls, PAS patients, placenta previa (PP) patients, and pre-eclamptic (PE) patients. Initial miRNA array screened 42 out of 768 serum miRNAs in the screening phase, and then validated four miRNAs by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
